Condition
Birth Length
Total Trials
4
Recruiting
0
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed2
Active Not Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04694235Not ApplicableActive Not Recruiting
Egg Intervention During Pregnancy in Indonesia
NCT04564222Not ApplicableActive Not RecruitingPrimary
Sustainable Intervention of Supplementation to Improve Kid's Growth Study
NCT04559152Not ApplicableCompleted
Zinc Supplementation During Pregnancy: Analysis of Maternal Serum Zinc, Cord Blood Osteocalcin and Neonatal Birth Length
NCT03312049Completed
Aflatoxin Birth Cohort Study Nepal (AflaCohort)
Showing all 4 trials